This study will use multiple levels of analysis to determine mechanisms by which amylin, a pancreatic-and-brain-derived peptide, acts in the mesolimbic reward system of the brain to reduce body weight and decrease food intake.
Caffeine is the most widely used psychoactive substance in the world and its use is increasing among children. Although considered safe, the majority of empirical data on the effects of caffeine have been collected in adults.
Mushrooms rich in vitamin D will be studied to help shed light on their effects on people with diabetes, the usefulness of a vegetarian vitamin D source, and how they may improve the quality of life for older adults.
This project will determine the magnitude of increases in core body temperature or reductions in body fluids incurred in a warm and humid disabled Pressurized Rescue Module scenario at sea level and at depth (20 feet of seawater) for up to 24 hours.
Todd C. Rideout, PhD, will test the combination of two nutraceuticals for potential application in the prevention and treatment of metabolic syndrome, a group of risk factors that contribute to increased cardiovascular disease.
Over 100 million individuals in the United States are obese, including the very young and the very old, a condition associated with insulin insensitivity, metabolic inflexibility, and reduced activities of daily living.
Sepsis is a leading cause of death in critical care units worldwide. This study, led by John X. Wilson, PhD, will explore whether something as simple as vitamin C can help reduce mortality from sepsis.